Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$cybn](/topic/$cybn)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cybn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cybn/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +10%  
**1 Month**: XX% +7%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-10-09  

**Most Supportive Themes**
- **Positive Clinical Trial Results:** (45%) Posts highlight positive outcomes from CYB003 and CYB004 trials, fueling optimism about the company's progress in psychedelic treatments.
- **Sector Momentum and Institutional Interest:** (30%) Mentions of increased trading volume and institutional interest in psychedelic stocks, including $CYBN, suggest growing confidence in the sector.
- **Regulatory Advancements:** (15%) News of FDA breakthrough therapy designation and supportive guidance for psychedelic development boosts investor sentiment.
  
**Most Critical Themes**
- **Market Volatility:** (10%)  Concerns about overall market conditions and their potential impact on the stock's performance are present.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXX      | XX% | XXX     | XX% | XXX      | XX% |
| TikTok  | X        | X%  | X       | X%  | X        | X%  |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXX      | XX% | XXX     | XX% | XXX      | XX% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$cybn

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +10%
1 Month: XX% +7%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-10-09

Most Supportive Themes

  • Positive Clinical Trial Results: (45%) Posts highlight positive outcomes from CYB003 and CYB004 trials, fueling optimism about the company's progress in psychedelic treatments.
  • Sector Momentum and Institutional Interest: (30%) Mentions of increased trading volume and institutional interest in psychedelic stocks, including $CYBN, suggest growing confidence in the sector.
  • Regulatory Advancements: (15%) News of FDA breakthrough therapy designation and supportive guidance for psychedelic development boosts investor sentiment.

Most Critical Themes

  • Market Volatility: (10%) Concerns about overall market conditions and their potential impact on the stock's performance are present.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XXX XX%
TikTok X X% X X% X X%
YouTube X X% X X% X X%
Total XXX XX% XXX XX% XXX XX%
$cybn Sentiment
/topic/$cybn/sentiment